A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis-Reference-Cited by-同舟云学术

A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis

Published:2020-09-20 Issue:1 Volume:12 Page:1814119
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Shelby Rita D.¹,Janzow Grace E.¹,Mashburn-Warren Lauren²,Galley Jeffrey¹,Tengberg Natalie¹,Navarro Jason³,Conces Miriam³,Bailey Michael T.²,Goodman Steven D.²,Besner Gail E.¹

Affiliation:

1. Center for Perinatal Research, The Research Institute at Nationwide Children’s Hospital, Department of Pediatric Surgery, Nationwide Children’s Hospital, Columbus, OH, USA

2. Center for Microbial Pathogenesis, The Research Institute at Nationwide Children’s Hospital, Columbus, OH, USA

3. Department of Pathology, Nationwide Children’s Hospital, Columbus, OH, USA

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2020.1814119

Reference34 articles.

1. Burden ofClostridium difficileInfection in the United States

2. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases

3. Probiotics for prevention of Clostridium difficile infection